Effect of cationic surfactant on transport of surface-active and non-surface-active model drugs and emulsion stability in triphasic systems

Ken ichi Hosoya, Kazuhiro Tetsuka, Katsuhiko Nagase, Masatoshi Tomi, Shigeki Saeki, Sumio Ohtsuki, Tetsuya Terasaki, Nobuaki Yanai, Masuo Obinata, Akihiko Kikuchi, Masuo Obinata, Hitomi Takanaga

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

A study was carried out to determine the effect of excess surfactant on transport kinetics in emulsions, using surface-active (phenobarbital, barbital) and non-surface-active (phenylazoaniline, benzocaine) model drugs (pH 7.0). Mineral oil was chosen as the oil phase, and the ionic surfactant cetyltrimethylammonium bromide (CTAB) was chosen as the emulsifier. The effect of nonionic surfactant Brij 97 on transport kinetics of these model drugs were determined by authors elsewhere. Model drug transport in the triphasic systems was investigated using side-by-side diffusion cells mounted with hydrophilic dialysis membranes (molecular weight cutoffs 1 kD and 50 kD) and a novel bulk equilibrium reverse dialysis bag technique. Emulsion stability was determined by droplet size analysis as a function of time, temperature, and the presence of model drugs using photon correlation spectroscopy. Mineral oil/water partition coefficients and aqueous solubilities were determined in the presence of surfactant. The droplet size of the CTAB-stabilized emulsion system is bigger than that of the Brij 97-stabilized system because of the relatively less dense interfacial packing of the cationic surfactant. CTAB forms a complex with the model drugs because of ionic interaction between CTAB and the aromatic and azo groups of the model drugs. This complexation is expected to increase emulsion stability and affect model drug transport kinetics. The transport rates of model drugs in emulsions increased with increases in CTAB micellar concentrations up to 0.5% w/v and then decreased at higher surfactant concentrations. Total transport rates of phenobarbital and barbital were faster than those of phenylazoaniline and benzocaine. Excess surfactant affected the transport rates of the model drugs in the emulsions depending on drug surface activity and lipophilicity. The transport profiles of the model drugs appeared to be governed by model drug oil/water partition coefficient values and by micellar shape changes at higher surfactant concentrations.

Original languageEnglish
Pages (from-to)E28
JournalAAPS PharmSci
Volume2
Issue number3
DOIs
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Drug Stability
Active Biological Transport
Emulsions
Surface-Active Agents
Pharmaceutical Preparations
Benzocaine
Barbital
Mineral Oil
Phenobarbital
Dialysis
Oils
Pharmacokinetics
Mineral Waters
Photons
Solubility
Spectrum Analysis
Molecular Weight
cetrimonium

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Effect of cationic surfactant on transport of surface-active and non-surface-active model drugs and emulsion stability in triphasic systems. / Hosoya, Ken ichi; Tetsuka, Kazuhiro; Nagase, Katsuhiko; Tomi, Masatoshi; Saeki, Shigeki; Ohtsuki, Sumio; Terasaki, Tetsuya; Yanai, Nobuaki; Obinata, Masuo; Kikuchi, Akihiko; Obinata, Masuo; Takanaga, Hitomi.

In: AAPS PharmSci, Vol. 2, No. 3, 2000, p. E28.

Research output: Contribution to journalArticle

Hosoya, KI, Tetsuka, K, Nagase, K, Tomi, M, Saeki, S, Ohtsuki, S, Terasaki, T, Yanai, N, Obinata, M, Kikuchi, A, Obinata, M & Takanaga, H 2000, 'Effect of cationic surfactant on transport of surface-active and non-surface-active model drugs and emulsion stability in triphasic systems', AAPS PharmSci, vol. 2, no. 3, pp. E28. https://doi.org/10.1208/ps020328
Hosoya, Ken ichi ; Tetsuka, Kazuhiro ; Nagase, Katsuhiko ; Tomi, Masatoshi ; Saeki, Shigeki ; Ohtsuki, Sumio ; Terasaki, Tetsuya ; Yanai, Nobuaki ; Obinata, Masuo ; Kikuchi, Akihiko ; Obinata, Masuo ; Takanaga, Hitomi. / Effect of cationic surfactant on transport of surface-active and non-surface-active model drugs and emulsion stability in triphasic systems. In: AAPS PharmSci. 2000 ; Vol. 2, No. 3. pp. E28.
@article{bf596b5f0a4446c0b22bca362e8edfc0,
title = "Effect of cationic surfactant on transport of surface-active and non-surface-active model drugs and emulsion stability in triphasic systems",
abstract = "A study was carried out to determine the effect of excess surfactant on transport kinetics in emulsions, using surface-active (phenobarbital, barbital) and non-surface-active (phenylazoaniline, benzocaine) model drugs (pH 7.0). Mineral oil was chosen as the oil phase, and the ionic surfactant cetyltrimethylammonium bromide (CTAB) was chosen as the emulsifier. The effect of nonionic surfactant Brij 97 on transport kinetics of these model drugs were determined by authors elsewhere. Model drug transport in the triphasic systems was investigated using side-by-side diffusion cells mounted with hydrophilic dialysis membranes (molecular weight cutoffs 1 kD and 50 kD) and a novel bulk equilibrium reverse dialysis bag technique. Emulsion stability was determined by droplet size analysis as a function of time, temperature, and the presence of model drugs using photon correlation spectroscopy. Mineral oil/water partition coefficients and aqueous solubilities were determined in the presence of surfactant. The droplet size of the CTAB-stabilized emulsion system is bigger than that of the Brij 97-stabilized system because of the relatively less dense interfacial packing of the cationic surfactant. CTAB forms a complex with the model drugs because of ionic interaction between CTAB and the aromatic and azo groups of the model drugs. This complexation is expected to increase emulsion stability and affect model drug transport kinetics. The transport rates of model drugs in emulsions increased with increases in CTAB micellar concentrations up to 0.5{\%} w/v and then decreased at higher surfactant concentrations. Total transport rates of phenobarbital and barbital were faster than those of phenylazoaniline and benzocaine. Excess surfactant affected the transport rates of the model drugs in the emulsions depending on drug surface activity and lipophilicity. The transport profiles of the model drugs appeared to be governed by model drug oil/water partition coefficient values and by micellar shape changes at higher surfactant concentrations.",
author = "Hosoya, {Ken ichi} and Kazuhiro Tetsuka and Katsuhiko Nagase and Masatoshi Tomi and Shigeki Saeki and Sumio Ohtsuki and Tetsuya Terasaki and Nobuaki Yanai and Masuo Obinata and Akihiko Kikuchi and Masuo Obinata and Hitomi Takanaga",
year = "2000",
doi = "10.1208/ps020328",
language = "English",
volume = "2",
pages = "E28",
journal = "AAPS Journal",
issn = "1550-7416",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Effect of cationic surfactant on transport of surface-active and non-surface-active model drugs and emulsion stability in triphasic systems

AU - Hosoya, Ken ichi

AU - Tetsuka, Kazuhiro

AU - Nagase, Katsuhiko

AU - Tomi, Masatoshi

AU - Saeki, Shigeki

AU - Ohtsuki, Sumio

AU - Terasaki, Tetsuya

AU - Yanai, Nobuaki

AU - Obinata, Masuo

AU - Kikuchi, Akihiko

AU - Obinata, Masuo

AU - Takanaga, Hitomi

PY - 2000

Y1 - 2000

N2 - A study was carried out to determine the effect of excess surfactant on transport kinetics in emulsions, using surface-active (phenobarbital, barbital) and non-surface-active (phenylazoaniline, benzocaine) model drugs (pH 7.0). Mineral oil was chosen as the oil phase, and the ionic surfactant cetyltrimethylammonium bromide (CTAB) was chosen as the emulsifier. The effect of nonionic surfactant Brij 97 on transport kinetics of these model drugs were determined by authors elsewhere. Model drug transport in the triphasic systems was investigated using side-by-side diffusion cells mounted with hydrophilic dialysis membranes (molecular weight cutoffs 1 kD and 50 kD) and a novel bulk equilibrium reverse dialysis bag technique. Emulsion stability was determined by droplet size analysis as a function of time, temperature, and the presence of model drugs using photon correlation spectroscopy. Mineral oil/water partition coefficients and aqueous solubilities were determined in the presence of surfactant. The droplet size of the CTAB-stabilized emulsion system is bigger than that of the Brij 97-stabilized system because of the relatively less dense interfacial packing of the cationic surfactant. CTAB forms a complex with the model drugs because of ionic interaction between CTAB and the aromatic and azo groups of the model drugs. This complexation is expected to increase emulsion stability and affect model drug transport kinetics. The transport rates of model drugs in emulsions increased with increases in CTAB micellar concentrations up to 0.5% w/v and then decreased at higher surfactant concentrations. Total transport rates of phenobarbital and barbital were faster than those of phenylazoaniline and benzocaine. Excess surfactant affected the transport rates of the model drugs in the emulsions depending on drug surface activity and lipophilicity. The transport profiles of the model drugs appeared to be governed by model drug oil/water partition coefficient values and by micellar shape changes at higher surfactant concentrations.

AB - A study was carried out to determine the effect of excess surfactant on transport kinetics in emulsions, using surface-active (phenobarbital, barbital) and non-surface-active (phenylazoaniline, benzocaine) model drugs (pH 7.0). Mineral oil was chosen as the oil phase, and the ionic surfactant cetyltrimethylammonium bromide (CTAB) was chosen as the emulsifier. The effect of nonionic surfactant Brij 97 on transport kinetics of these model drugs were determined by authors elsewhere. Model drug transport in the triphasic systems was investigated using side-by-side diffusion cells mounted with hydrophilic dialysis membranes (molecular weight cutoffs 1 kD and 50 kD) and a novel bulk equilibrium reverse dialysis bag technique. Emulsion stability was determined by droplet size analysis as a function of time, temperature, and the presence of model drugs using photon correlation spectroscopy. Mineral oil/water partition coefficients and aqueous solubilities were determined in the presence of surfactant. The droplet size of the CTAB-stabilized emulsion system is bigger than that of the Brij 97-stabilized system because of the relatively less dense interfacial packing of the cationic surfactant. CTAB forms a complex with the model drugs because of ionic interaction between CTAB and the aromatic and azo groups of the model drugs. This complexation is expected to increase emulsion stability and affect model drug transport kinetics. The transport rates of model drugs in emulsions increased with increases in CTAB micellar concentrations up to 0.5% w/v and then decreased at higher surfactant concentrations. Total transport rates of phenobarbital and barbital were faster than those of phenylazoaniline and benzocaine. Excess surfactant affected the transport rates of the model drugs in the emulsions depending on drug surface activity and lipophilicity. The transport profiles of the model drugs appeared to be governed by model drug oil/water partition coefficient values and by micellar shape changes at higher surfactant concentrations.

UR - http://www.scopus.com/inward/record.url?scp=84862709007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862709007&partnerID=8YFLogxK

U2 - 10.1208/ps020328

DO - 10.1208/ps020328

M3 - Article

VL - 2

SP - E28

JO - AAPS Journal

JF - AAPS Journal

SN - 1550-7416

IS - 3

ER -